Innovation and Technology Adoption in Health Care Markets - Jena, Anupam B.; Philipson, Tomas
13,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
payback
7 °P sammeln
  • Broschiertes Buch

Jena and Philipson argue that further use of cost-effectiveness thresholds to curb health care spending may do more harm than good. Governments should adopt a more inclusive way of costeffectiveness, one that reflects not only the short term costs to patients but also the long-term effect on medical innovation. Policy makers should provide sufficient incentives for companies to develop new health technologies - or risk a dangerous shortage of life-saving drugs in the future.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Jena and Philipson argue that further use of cost-effectiveness thresholds to curb health care spending may do more harm than good. Governments should adopt a more inclusive way of costeffectiveness, one that reflects not only the short term costs to patients but also the long-term effect on medical innovation. Policy makers should provide sufficient incentives for companies to develop new health technologies - or risk a dangerous shortage of life-saving drugs in the future.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Anupam B. Jena is a visiting fellow at the Bing Center for Health Economics at the RAND Corporation and a fellow in the Medical Scientist Training Program at the University of Chicago. Tomas J. Philipson is a visiting scholar at AEI and the Daniel Levin Professor at the University of Chicago's Irving B. Harris Graduate School of Public Policy.